A small peptide derived from Flt-1 (VEGFR-1) functions as an angiogenic inhibitor
10.1016/S0014-5793(01)02314-6
Saved in:
Main Authors: | Tan, D.C.W., Kini, R.Manjunatha, Jois, S.D.S., Lim, D.K.F., Xin, L., Ge, R. |
---|---|
Other Authors: | PHARMACY |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/99968 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Flt1/VEGFR1 heterozygosity causes transient embryonic edema
by: Otowa, Y, et al.
Published: (2020) -
Synergistic effect between human vascular endothelial growth factor and angiopoietin-1 combined with myoblast therapy for treatment of ischemically damaged hind limbs
by: NIAGARA MUHAMMAD IDRIS
Published: (2010) -
Skeletal myoblast based delivery of angiogenic growth factors: A comparison between angiopoietin-1 and VEGF gene delivery for therapeutic angiogenesis in the heart
by: Ye, L., et al.
Published: (2011) -
Skeletal myoblast based delivery of angiogenic growth factors: A comparison between angiopoietin-1 and VEGF gene delivery for therapeutic angiogenesis in the heart
by: Ye, L., et al.
Published: (2012) -
Skeletal myoblast based delivery of angiogenic growth factors: A comparison between angiopoietin-1 and VEGF gene delivery for therapeutic angiogenesis in the heart
by: Ye, L., et al.
Published: (2014)